Institutional Ownership Lineage Cell Therapeutics, Inc. (LCTX)
This table provides information about the institutional ownership of Lineage Cell Therapeutics, Inc. (LCTX). We have compiled data on the 134 institutions that hold shares in the stock, with a total of 106 Million shares, which have been reported (via 13F filing form) to have a value of $76.6 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Broadwood Capital Inc
New York, NY |
Feb 13, 2025 Q4 2024 |
41,666,255
shares
|
$28.7 Million
1.65% of portfolio
|
Q1 2024
Added 19.27%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
9,559,466
shares
|
$6.6 Million
0.0% of portfolio
|
Q2 2024
Added 12.54%
|
|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
8,632,928
shares
|
$5.96 Million
0.0% of portfolio
|
Q4 2024
Added 0.37%
|
|
Perceptive Advisors LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
7,236,843
shares
|
$4.99 Million
0.12% of portfolio
|
Q4 2024
New holding
|
|
Defender Capital, Llc.
|
Jan 23, 2025 Q4 2024 |
5,963,348
shares
|
$4.11 Million
1.17% of portfolio
|
Q4 2024
Added 19.21%
|
|
Raffles Associates LP
New York, NY |
Feb 14, 2025 Q4 2024 |
5,492,088
shares
|
$3.79 Million
3.26% of portfolio
|
Q4 2024
Added 21.84%
|
|
Alyeska Investment Group, L.P.
Chicago, IL |
Feb 14, 2025 Q4 2024 |
3,947,369
shares
|
$2.72 Million
0.01% of portfolio
|
Q4 2024
New holding
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
3,690,486
shares
|
$2.55 Million
0.0% of portfolio
|
Q4 2024
Added 0.3%
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
2,674,512
shares
|
$1.85 Million
0.0% of portfolio
|
Q4 2024
Added 2.54%
|
|
Dafna Capital Management LLC
Los Angeles, CA |
Feb 14, 2025 Q4 2024 |
2,511,374
shares
|
$1.73 Million
0.34% of portfolio
|
Q4 2024
Added 85.93%
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Feb 13, 2025 Q4 2024 |
2,283,072
shares
|
$1.58 Million
0.0% of portfolio
|
Q4 2024
Added 1058.33%
|
|
Northern Trust Corp
Chicago, IL |
Feb 14, 2025 Q4 2024 |
1,274,492
shares
|
$879,399
0.0% of portfolio
|
Q4 2024
Reduced 0.01%
|
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
Feb 14, 2025 Q4 2024 |
1,033,763
shares
|
$713,296
0.0% of portfolio
|
Q4 2024
New holding
|
|
Jpmorgan Chase & CO
New York, NY |
Feb 12, 2025 Q4 2024 |
946,399
shares
|
$653,015
0.0% of portfolio
|
Q4 2024
Added 39.76%
|
|
Comerica Bank
|
Feb 14, 2025 Q4 2024 |
800,000
shares
|
$552,000
0.0% of portfolio
|
Q4 2024
Added 220.0%
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
660,061
shares
|
$455,442
0.0% of portfolio
|
Q4 2024
Reduced 22.19%
|
|
Mai Capital Management
|
Feb 14, 2025 Q4 2024 |
657,679
shares
|
$453,798
0.0% of portfolio
|
Q4 2024
New holding
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
515,445
shares
|
$355,657
0.0% of portfolio
|
Q2 2023
New holding
|
|
Bridgeway Capital Management, LLC
Houston, TX |
Feb 14, 2025 Q4 2024 |
417,900
shares
|
$288,351
0.0% of portfolio
|
Q4 2024
Reduced 44.78%
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Feb 06, 2025 Q4 2024 |
416,223
shares
|
$287,193
0.0% of portfolio
|
Q3 2024
Reduced 0.05%
|
|
Gsa Capital Partners LLP
London, X0 |
Feb 07, 2025 Q4 2024 |
408,837
shares
|
$282,097
0.02% of portfolio
|
Q4 2024
Added 339.46%
|
|
Prescott General Partners LLC
Boca Raton, FL |
Feb 14, 2025 Q4 2024 |
386,000
shares
|
$266,340
0.01% of portfolio
|
Q3 2024
Reduced 37.74%
|
|
Goldman Sachs Group Inc
New York, NY |
Feb 11, 2025 Q4 2024 |
385,066
shares
|
$265,695
0.0% of portfolio
|
Q4 2024
Added 57.67%
|
|
Red Crane Wealth Management, LLC
San Francisco, CA |
Feb 04, 2025 Q4 2024 |
340,236
shares
|
$234,762
0.16% of portfolio
|
Q4 2024
New holding
|
|
ETF Managers Group, LLC
Summit, NJ |
Apr 17, 2023 Q1 2023 |
318,596
shares
|
$219,831
0.02% of portfolio
|
Q1 2023
Reduced 10.0%
|